IO Biotech, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 26.18 million compared to USD 20.07 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.7 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +5.33% | +3.27% | -15.96% |
Apr. 26 | IO Biotech, Inc. Announces Resignation of Jack Nielsen as Member of the Board of Directors | CI |
Apr. 15 | IO Biotech Announces Marjan Shamsaei as Senior Vice President | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.96% | 98.82M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- IO Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023